GO
Loading...

Acquisitions

More

  • UPDATE 1-Pfizer confirms desire to buy AstraZeneca Monday, 28 Apr 2014 | 2:28 AM ET

    LONDON, April 28- U.S. drugmaker Pfizer made a bid approach to AstraZeneca in January and contacted its British rival again on April 26 seeking to renew discussions about a takeover, the U.S. firm said on Monday. A Pfizer bid for AstraZeneca would be one of the largest ever pharmaceuticals deals.

  • April 27- German drugmaker Bayer AG is exploring the sale of its $10 billion plastics unit to focus on growing its health business, Bloomberg reported citing people with knowledge of the matter.

  • April 25- Prestige Brands Holdings Inc, a marketer and distributor of healthcare and cleaning products, said it would buy rival Insight Pharmaceuticals Corp for $750 million in cash to expand its range of feminine care products.

  • GE in talks to buy Alstom: Report     Thursday, 24 Apr 2014 | 6:09 AM ET

    Nicholas Heyman, William Blair, discusses General Electric's possible acquisition of French train and power plant builder Alstom for more than $13 billion.

  • Einhorn's new course     Tuesday, 22 Apr 2014 | 2:31 PM ET

    Sandy Villere, Villere Funds, shares his thoughts on Greenlight Capital's new stake in Conn's.

  • Eli Lilly Chairman & CEO John Lechleiter discusses his business' expansion of its animal health unit with the acquisition of Novartis' animal health business.

  • GlaxoSmithKline CEO Sir Andrew Witty, explains the large portfolio of vaccinations his company provides, and the value added from the company's acquisition of Novartis' vaccination business.

  • Novartis acquisition adds 'tremendous value'     Tuesday, 22 Apr 2014 | 6:45 AM ET

    GlaxoSmithKline CEO Sir Andrew Witty, discusses the benefit to shareholders from his company's acquisition of Novartis' vaccination business, as well as its oncology unit.

  • PwC strikes deal to buy Booz     Thursday, 3 Apr 2014 | 7:16 AM ET

    Bob Moritz, PricewaterhouseCoopers chairman and senior partner, discusses the company's plan to boost its consulting business by extending its global reach.

  • Marriott completes deal to acquire Protea     Tuesday, 1 Apr 2014 | 8:16 AM ET

    Arne Sorenson, CEO & president of Marriott International, discusses his company's acquisition of the largest hotel company in Africa.

  • How activist investors influence M&A     Friday, 28 Mar 2014 | 8:16 AM ET

    Michael Carr, Goldman Sachs M&A group in the Americas, shares his thoughts on the role of activists in deal making and the outlook for mergers and acquisitions.

  • 'Poison Pill' inventor targets activism     Friday, 28 Mar 2014 | 7:34 AM ET

    Activism in the long-term is not only bad for shareholders but also bad for the economy as a whole, says Martin Lipton, Wachtell, Lipton, Rosen & Katz, expressing his views on shareholder activism. Also Lipton shares his thoughts on the two categories of hedge fund activism.

  • Your guide to understanding 4 mega-deals     Friday, 28 Mar 2014 | 6:30 AM ET

    It's been a robust 12 months of mergers and buyouts. Here's an inside look at four high-profile deals from Facebook-WhatsApp to Warren Buffett's involvement with Heinz.

  • Market doesn't like FB's Oculus purchase     Wednesday, 26 Mar 2014 | 4:17 PM ET

    Discussing Facebook's decision to purchase virtual reality technology company Oculus VR for $2 billion, with Dennis Berman, The Wall Street Journal.

  • Facebook's Zuckerberg thinks in decades: Pro     Wednesday, 26 Mar 2014 | 2:06 PM ET

    Discussing Facebook's decision to purchase virtual reality technology company Oculus for $2 billion, with Mike Isaac, Re/code senior editor.

  • Facebook's Oculus purchase 'brilliant'     Wednesday, 26 Mar 2014 | 1:18 PM ET

    Facebook purchased virtual reality technology company Oculus for $2 billion. Stephan Paterno, Slated CEO & co-founder, says Mark Zuckerberg is making an "offensive bet."

  • Facebook purchases Oculus     Wednesday, 26 Mar 2014 | 1:17 PM ET

    Facebook purchased virtual reality technology company Oculus for $2 billion, reports CNBC's Josh Lipton.

  • Facebook's spending spree     Wednesday, 26 Mar 2014 | 12:15 PM ET

    Facebook purchased virtual reality technology company Oculus for $2 billion just five weeks after announcing a $16 billion deal to buy WhatsApp, reports CNBC's Josh Lipton. The FMHR traders provide perspective.

  • Tech guru 'commends Mark Zuckerberg'     Wednesday, 26 Mar 2014 | 12:15 PM ET

    Facebook acquired virtual reality technology company Oculus for $2 billion. John McDuling of Quartz thinks the Oculus acquisition is more ambitious than the WhatsApp purchase.

  • Facebook buys Oculus for $2 billion     Wednesday, 26 Mar 2014 | 7:06 AM ET

    The social media giant is getting into the virtual reality game, reports CNBC's Jon Fortt with details of the deal and a look at how Oculus works.